Glucagon-like peptide-2 and its therapeutic use

   
   

Glucagon-like peptide 2, a product of glucagon gene expression, has been identified as a gastrointestinal tissue growth factor. Its effects on the growth of small intestine and on pancreatic islets are described. Its formulation as a pharmaceutical, and its therapeutic use in treating bowel tissue disorders and in treating diabetes, are described.

Glucagon-como el peptide 2, un producto de la expresión del gene del glucagon, se ha identificado como factor gastrointestinal del crecimiento del tejido fino. Sus efectos sobre el crecimiento del intestino pequeño y sobre los islotes pancreáticos se describen. Su formulación como uso farmacéutico, y su terapéutico en desórdenes del tejido fino del intestino que tratan y en tratar la diabetes, se describe.

 
Web www.patentalert.com

< Buccal delivery of glucagon-like insulinotropic peptides

< Insulinotropic hormones and uses thereof

> In vivo production and delivery of erythropoietin or insulinotropin for gene therapy

> Insulinotropic hormone

~ 00124